Adaptive Biotechnologies Corporation reiterated revenue guidance for the full year 2023. The company reiterates full year 2023 revenue to be in the range of $205 million to $215 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 USD | +4.21% | +27.33% | -19.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.18% | 560M | |
-27.01% | 10.26B | |
+31.86% | 3.04B | |
-8.58% | 2.94B | |
-13.62% | 2.19B | |
-16.32% | 1.72B | |
+63.36% | 1.4B | |
+27.00% | 780M | |
-2.18% | 736M | |
+3.18% | 293M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Reiterates Revenue Guidance for the Full Year 2023